Abstract
Background The ChatGPT is an artificial intelligence chatbot that processes natural language text learned through reinforcement learning based on the GPT-3.5 architecture, a large-scale language model. Natural language processing models are being used in various fields and are gradually expanding their use in the medical field.
Purpose This study aimed to investigate the medical information and treatment options that ChatGPT can provide for SIS.
Method Using ChatGPT, which is provided as a free beta test, messages related to SIS were entered, and responses to medical information and treatment options were received and analyzed.
Result ChatGPT not only provided answers to the definition, prevalence, and risk factors of SIS, but also symptoms, diseases with similar symptoms, and orthopedic tests according to the messages input. Additionally, a list of treatment options and exercises were provided.
Conclusion ChatGPT will be able to provide overall useful medical information and treatment options to patients unfamiliar with SIS. However, caution is required as it contains content that may be biased or inappropriate information for patients with SIS. Nevertheless, if natural language processing technology develops further, it is expected to be able to express more detailed medical information and treatment options.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
None
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
The author's affiliation and part of the abstract have been modified (2022-12-19).
